Pricing Log in Create free account

Fulcrum Therapeutics, Inc. (FULC) vs Nautilus Biotechnology, Inc. (NAUT)

Fulcrum Therapeutics, Inc. and Nautilus Biotechnology, Inc. are both Biotechnology companies. Fulcrum Therapeutics, Inc. and Nautilus Biotechnology, Inc. are of similar size ($280.0M and $274.9M). Across the 10 metrics below, Fulcrum Therapeutics, Inc. leads on 5 and Nautilus Biotechnology, Inc. on 5.

Valuation

Metric FULC NAUT Biotechnology median
P/E n/m n/m 8.50
P/S 3.37 n/m 9.71
P/B 0.90 2.00 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.43 n/m 0.64
EV/Sales (0.49) n/m 9.21
Earnings yield (33.15%) (21.84%) (33.15%)
Free cash flow yield (23.60%) (19.80%) (25.50%)

Profitability

Metric FULC NAUT Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (32.38%) (36.21%) (56.36%)
Return on assets (30.75%) (30.00%) (48.04%)
Return on invested capital 0.00% (83.32%) 0.00%

Growth

Metric FULC NAUT Biotechnology median
Revenue growth (TTM) 1,939.80% — 6.02%
EPS growth (last fiscal year) (637.50%) 16.07% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric FULC NAUT Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 31.35 10.14 4.72
Net debt to EBITDA 4.23 1.67 0.96

Dividend

Metric FULC NAUT Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric FULC NAUT Biotechnology median
Market cap 280.01m 274.87m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack